Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1 - PubMed (original) (raw)
Comparative Study
Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1
D R Alessi et al. EMBO J. 1994.
Abstract
Many growth factors whose receptors are protein tyrosine kinases stimulate the MAP kinase pathway by activating first the GTP-binding protein Ras and then the protein kinase p74raf-1. p74raf-1 phosphorylates and activates MAP kinase kinase (MAPKK). To understand the mechanism of activation of MAPKK, we have identified Ser217 and Ser221 of MAPKK1 as the sites phosphorylated by p74raf-1. This represents the first characterization of sites phosphorylated by this proto-oncogene product. Ser217 and Ser221 lie in a region of the catalytic domain where the activating phosphorylation sites of several other protein kinases are located. Among MAPKK family members, this region is the most conserved, suggesting that all members of the family are activated by the phosphorylation of these sites. A 'kinase-dead' MAPKK1 mutant was phosphorylated at the same residues as the wild-type enzyme, establishing that both sites are phosphorylated directly by p74raf-1, and not by autophosphorylation. Only the diphosphorylated form of MAPKK1 (phosphorylated at both Ser217 and Ser221) was detected, even when the stoichiometry of phosphorylation by p74raf-1 was low, indicating that phosphorylation of one of these sites is rate limiting, phosphorylation of the second then occurring extremely rapidly. Ser217 and Ser221 were both phosphorylated in vivo within minutes when PC12 cells were stimulated with nerve growth factor. Analysis of MAPKK1 mutants in which either Ser217 or Ser221 were changed to glutamic acid, and the finding that inactivation of maximally activated MAPKK1 required the dephosphorylation of both serines, shows that phosphorylation of either residue is sufficient for maximal activation.
Similar articles
- PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo.
Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. Alessi DR, et al. J Biol Chem. 1995 Nov 17;270(46):27489-94. doi: 10.1074/jbc.270.46.27489. J Biol Chem. 1995. PMID: 7499206 - A dominant-negative mutant of raf blocks mitogen-activated protein kinase activation by growth factors and oncogenic p21ras.
Schaap D, van der Wal J, Howe LR, Marshall CJ, van Blitterswijk WJ. Schaap D, et al. J Biol Chem. 1993 Sep 25;268(27):20232-6. J Biol Chem. 1993. PMID: 8397201 - Characterization of recombinant Xenopus MAP kinase kinases mutated at potential phosphorylation sites.
Gotoh Y, Matsuda S, Takenaka K, Hattori S, Iwamatsu A, Ishikawa M, Kosako H, Nishida E. Gotoh Y, et al. Oncogene. 1994 Jul;9(7):1891-8. Oncogene. 1994. PMID: 8208535 - Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation.
Marais R, Light Y, Paterson HF, Marshall CJ. Marais R, et al. EMBO J. 1995 Jul 3;14(13):3136-45. doi: 10.1002/j.1460-2075.1995.tb07316.x. EMBO J. 1995. PMID: 7542586 Free PMC article. - Determination of v-Mos-catalyzed phosphorylation sites and autophosphorylation sites on MAP kinase kinase by ESI/MS.
Resing KA, Mansour SJ, Hermann AS, Johnson RS, Candia JM, Fukasawa K, Vande Woude GF, Ahn NG. Resing KA, et al. Biochemistry. 1995 Feb 28;34(8):2610-20. doi: 10.1021/bi00008a027. Biochemistry. 1995. PMID: 7873542
Cited by
- Structural and functional effects of phosphopriming and scaffolding in the kinase GSK-3β.
Enos MD, Gavagan M, Jameson N, Zalatan JG, Weis WI. Enos MD, et al. Sci Signal. 2024 Sep 3;17(852):eado0881. doi: 10.1126/scisignal.ado0881. Epub 2024 Sep 3. Sci Signal. 2024. PMID: 39226374 - Hyperactivation of MEK1 in cortical glutamatergic neurons results in projection axon deficits and aberrant motor learning.
Bjorklund GR, Rees KP, Balasubramanian K, Hewitt LT, Nishimura K, Newbern JM. Bjorklund GR, et al. Dis Model Mech. 2024 Jun 1;17(6):dmm050570. doi: 10.1242/dmm.050570. Epub 2024 Jul 2. Dis Model Mech. 2024. PMID: 38826084 Free PMC article. - A strategy to disentangle direct and indirect effects on (de)phosphorylation by chemical modulators of the phosphatase PP1 in complex cellular contexts.
Hoermann B, Dürr EM, Ludwig C, Ercan M, Köhn M. Hoermann B, et al. Chem Sci. 2024 Jan 12;15(8):2792-2804. doi: 10.1039/d3sc04746f. eCollection 2024 Feb 22. Chem Sci. 2024. PMID: 38404380 Free PMC article. - The Minimum Protein Staple? - Towards 'bio'-Baldwin's rules via inter-phosphosite linking in the MEK1 activation loop.
Galan SRG, Raj R, Mamalis D, Jones LH, Mohammed S, Davis BG. Galan SRG, et al. Chem Sci. 2023 Dec 1;15(4):1306-1317. doi: 10.1039/d3sc04631a. eCollection 2024 Jan 24. Chem Sci. 2023. PMID: 38274071 Free PMC article. - MEK inhibitors in cancer treatment: structural insights, regulation, recent advances and future perspectives.
Ram T, Singh AK, Kumar A, Singh H, Pathak P, Grishina M, Khalilullah H, Jaremko M, Emwas AH, Verma A, Kumar P. Ram T, et al. RSC Med Chem. 2023 Aug 10;14(10):1837-1857. doi: 10.1039/d3md00145h. eCollection 2023 Oct 18. RSC Med Chem. 2023. PMID: 37859720 Free PMC article. Review.
References
- Eur J Biochem. 1980 Sep;110(1):167-77 - PubMed
- Biochem J. 1993 Dec 15;296 ( Pt 3):843-9 - PubMed
- Anal Biochem. 1986 Apr;154(1):250-4 - PubMed
- Proc Natl Acad Sci U S A. 1986 Oct;83(19):7371-5 - PubMed
- Nature. 1987 May 7-13;327(6117):31-5 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases